| 95556-7 | Adrenal ca risk assess+ur steroid Pnl | 66 |
| 95619-3 | Hurts, insults, threatens, and screams:-:12Mo:^Patient:-:HITS | 16 |
| 95620-1 | NPASS pnl | 3 |
| 95621-9 | Pain/agitat pnl NPASS | 8 |
| 95629-2 | Sed pnl NPASS | 7 |
| 95732-4 | IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - admission performance:-:RptPeriod:^Patient:-:CMS Assessment | 49 |
| 95733-2 | IRF-PAI v3.0, LCDS v4.00 - Bladder and bowel - admission:-:RptPeriod:^Patient:-:CMS Assessment | 10 |
| 95734-0 | IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance:-:RptPeriod:^Patient:-:CMS Assessment | 70 |
| 95741-5 | IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - admission performance:-:RptPeriod:^Patient:-:CMS Assessment | 140 |
| 95742-3 | IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - discharge performance:-:RptPeriod:^Patient:-:CMS Assessment | 200 |
| 95796-9 | Opioids Pnl Ur Scn | 36 |
| 95800-9 | Immunoglobulin LC free Pnl Ur | 8 |
| 95801-7 | Immunoglobulin LC free + IFE Pnl Ur | 5 |
| 95808-2 | Cholest+triglyceride+chylomicrons Pnl Ur | 4 |
| 95810-8 | IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - discharge:-:RptPeriod:^Patient:-:CMS Assessment | 18 |
| 95811-6 | IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - admission:-:-:^Patient:-:CMS Assessment | 36 |
| 95816-5 | Signs and Symptoms of Delirium (from CAM):-:RptPeriod:^Patient:-:CMS Assessment | 184 |
| 95826-4 | SARS-CoV-2 RNA Pnl Sal NAA+probe | 9 |
| 95828-0 | T cell product panel BPU FC | 13 |
| 95830-6 | HPC product panel BPU FC | 27 |
| 95846-2 | Cell Cnt + Diff Pnl Spt Manual | 9 |
| 95851-2 | GH p Macimorelin Stil Pnl Ser IA | 5 |
| 95852-0 | LCDS v4.00 - Signs and Symptoms of Delirium (from CAM):-:RptPeriod:^Patient:-:CMS Assessment | 12 |
| 95853-8 | LCDS v4.00 - Acute onset and fluctuating course:-:RptPeriod:^Patient:-:CMS Assessment | 6 |
| 95854-6 | LCDS v4.00 - Cognitive patterns:-:RptPeriod:^Patient:-:CMS Assessment | 3 |
| 95856-1 | LCDS v4.00 - Altered level of consciousness:-:RptPeriod:^Patient:-:CMS Assessment | 6 |
| 95859-5 | LCDS v4.00 - Self-care - admission performance:-:RptPeriod:^Patient:-:CMS Assessment | 11 |
| 95860-3 | LCDS v4.00 - Self-care - discharge goal:-:RptPeriod:^Patient:-:CMS Assessment | 2 |
| 95861-1 | LCDS v4.00 - Self-care - discharge performance:-:RptPeriod:^Patient:-:CMS Assessment | 11 |
| 95862-9 | LCDS v4.00 - Mobility - discharge goal:-:RptPeriod:^Patient:-:CMS Assessment | 11 |
| 95863-7 | LCDS v4.00 - Bladder and bowel - planned discharge:-:RptPeriod:^Patient:-:CMS Assessment | 5 |
| 95864-5 | LCDS v4.00 - Active diagnoses:-:RptPeriod:^Patient:-:CMS Assessment | 9 |
| 95865-2 | LCDS v4.00 - Swallowing &or nutritional status:-:RptPeriod:^Patient:-:CMS Assessment | 1 |
| 95866-0 | BRIEF health literacy screening tool:-:Pt:^Patient:-:BRIEF | 6 |
| 95872-8 | Brief cognitive assessment tool short form:-:Pt:^Patient:-:BCAT | 3 |
| 95875-1 | Brief anxiety and depression scale:-:Pt:^Patient:-:BADS | 4 |
| 95892-6 | Healthcare personnel status:-:Pt:^Event:-:CDC.EOC | 10 |
| 95893-4 | Hospital or facility beds utilization panel:-:Pt:^Event:-:CDC.EOC | 12 |
| 95918-9 | Fungal path panel Tiss NAA+probe | 5 |
| 95919-7 | Fungal path panel Lower resp NAA+probe | 5 |
| 95930-4 | Pulm vasodil pnl | 3 |
| 95941-1 | FLUABV+SARS-CoV-2+RSV Pnl Resp NAA+probe | 8 |
| 95942-9 | FLUABV+SARS-CoV Ag Pnl Up resp IA.rapid | 4 |
| 95943-7 | IRF-PAI v3.0 - Hearing, speech, and vision - admission:-:RptPeriod:^Patient:-:CMS Assessment | 2 |
| 95944-5 | IRF-PAI v3.0 - Staff assessment for mental status:-:RptPeriod:^Patient:-:CMS Assessment | 3 |
| 95945-2 | IRF-PAI v3.0 - Swallowing &or nutritional status - admission:-:RptPeriod:^Patient:-:CMS Assessment | 1 |
| 95974-2 | SARS-CoV-2 IFN-g Pnl Bld | 7 |
| 95975-9 | Skindex-16:-:1W:^Patient:-:Skindex-16 | 21 |
| 95996-5 | Skindex-29:-:4W:^Patient:-:Skindex-29 | 35 |
| 96034-4 | Skindex mini:-:1W:^Patient:-:Skindex mini | 4 |